Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- BAVENCIO
Descriptions
Avelumab injection is used to treat metastatic Merkel cell carcinoma (skin cancer that has already spread).
Avelumab injection is also used to treat urothelial carcinoma, a type of bladder cancer, that has spread throughout the body (metastatic) or cannot be removed by surgery (advanced). This medicine is given to patients who have received other cancer medicines (eg, platinum) that did not work well. It is also used as first-line maintenance treatment with urothelial carcinoma that has spread in patients who have responded well with platinum-containing cancer medicines.
Avelumab injection is also used together with other medicines (eg, axitinib) as first-line treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer.
Avelumab belongs to the group of medicines called antineoplastics. It helps change the immune system to help control the growth of cancer cells.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Aug. 01, 2020
Copyright © 2020 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.